INNOVATION PHARMACEUTICALS INC. Deferred Costs, Current
INNOVATION PHARMACEUTICALS INC. had Deferred Costs, Current of $0 as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2023-11-20
- 2023-09-30: Deferred Costs, Current $0.00.
- 2023-06-30: Deferred Costs, Current $0.00.
- 2023-03-31: Deferred Costs, Current $0.00.
- 2022-12-31: Deferred Costs, Current $0.00.
| Period end | Deferred Costs, Current |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-20 |
| 2023-06-30 | $0.00 10-Q · filed 2023-11-20 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 |
| 2022-12-31 | $0.00 10-Q · filed 2023-02-15 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $59.00K 10-K · filed 2023-09-28 |
| 2022-03-31 | $240.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $419.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $599.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $778.00K 10-K · filed 2022-09-28 |
| 2021-03-31 | $958.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.14M 10-Q · filed 2021-02-22 |
| 2020-09-30 | $1.32M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $0.00 10-K · filed 2021-09-27 |